Dermatop label

Dermatop

Dermatop Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

DERMATOP Ointment 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

DERMATOP® Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic agents. Each gram of DERMATOP Ointment 0.1% contains 1.0mg of prednicarbate in a base consisting of white petrolatum, octyldodecanol, glyceryl oleate, propylene glycol, citric acid, and propyl gallate.

Prednicarbate has the empirical formula C27H36O8 and a molecular weight of 488.58. The CAS Registry Number is 73771-04-7. The chemical structure is:

Chemical Structure
Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Dermatop Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Dermatop Manufacturers

  • Dermik Laboratories
    Dermatop | Dermik Laboratories
    No Recall

    Dermatop | Dermik Laboratories

    Dermatop | Dermik Laboratories

    Apply a thin film of DERMATOP Ointment 0.1% to the affected skin areas twice daily. Rub in gently.

  • Valeant Pharmaceuticals North America Llc
    Dermatop | Valeant Pharmaceuticals North America Llc
    No Recall

    Dermatop | Valeant Pharmaceuticals North America Llc

    Dermatop | Valeant Pharmaceuticals North America Llc

    Apply a thin film of DERMATOP Ointment 0.1% to the affected skin areas twice daily. Rub in gently.

  • Valeant Pharmaceuticals North America Llc
    Dermatop | Valeant Pharmaceuticals North America Llc
    No Recall

    Dermatop | Valeant Pharmaceuticals North America Llc

    Dermatop | Valeant Pharmaceuticals North America Llc

    Apply a thin film of DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1% to the affected skin areas twice daily. Rub in gently.

    DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1 % may be used in pediatric patients 1 year of age or older. Safety and efficacy of DERMATOP Emollient Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established. Use in pediatric patients under 1 year of age is not recommended.

    As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

    DERMATOP Emollient Cream 0.1% should not be used with occlusive dressings unless directed by the physician. DERMATOP Emollient Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.

  • Dermik Laboratories
    Dermatop | Dermik Laboratories
    No Recall

    Dermatop | Dermik Laboratories

    Dermatop | Dermik Laboratories

    Apply a thin film of DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1% to the affected skin areas twice daily. Rub in gently.

    DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1 % may be used in pediatric patients 1 year of age or older. Safety and efficacy of DERMATOP Emollient Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established. Use in pediatric patients under 1 year of age is not recommended.

    As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

    DERMATOP Emollient Cream 0.1% should not be used with occlusive dressings unless directed by the physician. DERMATOP Emollient Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.

Login To Your Free Account